Incidence of adverse drug events and medication errors in Japan: The JADE study

Takeshi Morimoto, Mio Sakuma, Kunihiko Matsui, Nobuo Kuramoto, Jinichi Toshiro, Junji Murakami, Tsuguya Fukui, Mayuko Saito, Atsushi Hiraide, David W. Bates

Research output: Contribution to journalArticle

Abstract

BACKGROUND: The epidemiology of adverse drug events (ADEs) and medication errors has received little evaluation outside the U.S. and Europe, and extrapolating from these data might not be valid, especially regarding selecting and prioritizing solutions. OBJECTIVE: To assess the incidence and preventability of ADEs and medication errors in Japan. DESIGN: The Japan Adverse Drug Events (JADE) study was a prospective cohort study. PATIENTS: A cohort of 3,459 adults admitted to a stratified random sample of seven medical and eight surgical wards and three intensive care units in three tertiary care hospitals over 6 months. MAIN MEASURES: We measured ADE and medication error rates from daily reviews of charts, laboratories, incident reports, and prescription queries by on-site reviewers; presence of a signal was considered an incident. Two independent physicians reviewed incidents to determine whether they were ADEs or medication errors and to assess severity and preventability. KEY RESULTS: We identified 1,010 ADEs and 514 medication errors (incidence: 17.0 and 8.7 per 1,000 patient-days, respectively) during the study period. Among ADEs, 1.6%, 4.9% and 33% were fatal, life-threatening and serious, respectively. Among ADEs, 14% were preventable. The rate per admission was 29 per 100 admissions, higher than in U.S. studies because associated with of the long length of hospital stay in Japan (mean, 17 days). CONCLUSIONS: The epidemiology and nature of ADEs and medication errors in Japan were similar to other countries, although more frequent per admission. Solutions that worked in these countries might thus improve medication safety in Japan, as could shortening hospital length of stay.

Original languageEnglish (US)
Pages (from-to)148-153
Number of pages6
JournalJournal of General Internal Medicine
Volume26
Issue number2
DOIs
StatePublished - Feb 2011
Externally publishedYes

Fingerprint

Medication Errors
Drug-Related Side Effects and Adverse Reactions
Japan
Incidence
Length of Stay
Epidemiology
Tertiary Healthcare
Tertiary Care Centers
Prescriptions
Intensive Care Units
Cohort Studies
Prospective Studies
Physicians
Safety

Keywords

  • adverse drug events
  • epidemiology
  • medication errors
  • patient safety

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Morimoto, T., Sakuma, M., Matsui, K., Kuramoto, N., Toshiro, J., Murakami, J., ... Bates, D. W. (2011). Incidence of adverse drug events and medication errors in Japan: The JADE study. Journal of General Internal Medicine, 26(2), 148-153. https://doi.org/10.1007/s11606-010-1518-3

Incidence of adverse drug events and medication errors in Japan : The JADE study. / Morimoto, Takeshi; Sakuma, Mio; Matsui, Kunihiko; Kuramoto, Nobuo; Toshiro, Jinichi; Murakami, Junji; Fukui, Tsuguya; Saito, Mayuko; Hiraide, Atsushi; Bates, David W.

In: Journal of General Internal Medicine, Vol. 26, No. 2, 02.2011, p. 148-153.

Research output: Contribution to journalArticle

Morimoto, T, Sakuma, M, Matsui, K, Kuramoto, N, Toshiro, J, Murakami, J, Fukui, T, Saito, M, Hiraide, A & Bates, DW 2011, 'Incidence of adverse drug events and medication errors in Japan: The JADE study', Journal of General Internal Medicine, vol. 26, no. 2, pp. 148-153. https://doi.org/10.1007/s11606-010-1518-3
Morimoto, Takeshi ; Sakuma, Mio ; Matsui, Kunihiko ; Kuramoto, Nobuo ; Toshiro, Jinichi ; Murakami, Junji ; Fukui, Tsuguya ; Saito, Mayuko ; Hiraide, Atsushi ; Bates, David W. / Incidence of adverse drug events and medication errors in Japan : The JADE study. In: Journal of General Internal Medicine. 2011 ; Vol. 26, No. 2. pp. 148-153.
@article{f2d8ede350bf4db79834836145655976,
title = "Incidence of adverse drug events and medication errors in Japan: The JADE study",
abstract = "BACKGROUND: The epidemiology of adverse drug events (ADEs) and medication errors has received little evaluation outside the U.S. and Europe, and extrapolating from these data might not be valid, especially regarding selecting and prioritizing solutions. OBJECTIVE: To assess the incidence and preventability of ADEs and medication errors in Japan. DESIGN: The Japan Adverse Drug Events (JADE) study was a prospective cohort study. PATIENTS: A cohort of 3,459 adults admitted to a stratified random sample of seven medical and eight surgical wards and three intensive care units in three tertiary care hospitals over 6 months. MAIN MEASURES: We measured ADE and medication error rates from daily reviews of charts, laboratories, incident reports, and prescription queries by on-site reviewers; presence of a signal was considered an incident. Two independent physicians reviewed incidents to determine whether they were ADEs or medication errors and to assess severity and preventability. KEY RESULTS: We identified 1,010 ADEs and 514 medication errors (incidence: 17.0 and 8.7 per 1,000 patient-days, respectively) during the study period. Among ADEs, 1.6{\%}, 4.9{\%} and 33{\%} were fatal, life-threatening and serious, respectively. Among ADEs, 14{\%} were preventable. The rate per admission was 29 per 100 admissions, higher than in U.S. studies because associated with of the long length of hospital stay in Japan (mean, 17 days). CONCLUSIONS: The epidemiology and nature of ADEs and medication errors in Japan were similar to other countries, although more frequent per admission. Solutions that worked in these countries might thus improve medication safety in Japan, as could shortening hospital length of stay.",
keywords = "adverse drug events, epidemiology, medication errors, patient safety",
author = "Takeshi Morimoto and Mio Sakuma and Kunihiko Matsui and Nobuo Kuramoto and Jinichi Toshiro and Junji Murakami and Tsuguya Fukui and Mayuko Saito and Atsushi Hiraide and Bates, {David W.}",
year = "2011",
month = "2",
doi = "10.1007/s11606-010-1518-3",
language = "English (US)",
volume = "26",
pages = "148--153",
journal = "Journal of General Internal Medicine",
issn = "0884-8734",
publisher = "Springer New York",
number = "2",

}

TY - JOUR

T1 - Incidence of adverse drug events and medication errors in Japan

T2 - The JADE study

AU - Morimoto, Takeshi

AU - Sakuma, Mio

AU - Matsui, Kunihiko

AU - Kuramoto, Nobuo

AU - Toshiro, Jinichi

AU - Murakami, Junji

AU - Fukui, Tsuguya

AU - Saito, Mayuko

AU - Hiraide, Atsushi

AU - Bates, David W.

PY - 2011/2

Y1 - 2011/2

N2 - BACKGROUND: The epidemiology of adverse drug events (ADEs) and medication errors has received little evaluation outside the U.S. and Europe, and extrapolating from these data might not be valid, especially regarding selecting and prioritizing solutions. OBJECTIVE: To assess the incidence and preventability of ADEs and medication errors in Japan. DESIGN: The Japan Adverse Drug Events (JADE) study was a prospective cohort study. PATIENTS: A cohort of 3,459 adults admitted to a stratified random sample of seven medical and eight surgical wards and three intensive care units in three tertiary care hospitals over 6 months. MAIN MEASURES: We measured ADE and medication error rates from daily reviews of charts, laboratories, incident reports, and prescription queries by on-site reviewers; presence of a signal was considered an incident. Two independent physicians reviewed incidents to determine whether they were ADEs or medication errors and to assess severity and preventability. KEY RESULTS: We identified 1,010 ADEs and 514 medication errors (incidence: 17.0 and 8.7 per 1,000 patient-days, respectively) during the study period. Among ADEs, 1.6%, 4.9% and 33% were fatal, life-threatening and serious, respectively. Among ADEs, 14% were preventable. The rate per admission was 29 per 100 admissions, higher than in U.S. studies because associated with of the long length of hospital stay in Japan (mean, 17 days). CONCLUSIONS: The epidemiology and nature of ADEs and medication errors in Japan were similar to other countries, although more frequent per admission. Solutions that worked in these countries might thus improve medication safety in Japan, as could shortening hospital length of stay.

AB - BACKGROUND: The epidemiology of adverse drug events (ADEs) and medication errors has received little evaluation outside the U.S. and Europe, and extrapolating from these data might not be valid, especially regarding selecting and prioritizing solutions. OBJECTIVE: To assess the incidence and preventability of ADEs and medication errors in Japan. DESIGN: The Japan Adverse Drug Events (JADE) study was a prospective cohort study. PATIENTS: A cohort of 3,459 adults admitted to a stratified random sample of seven medical and eight surgical wards and three intensive care units in three tertiary care hospitals over 6 months. MAIN MEASURES: We measured ADE and medication error rates from daily reviews of charts, laboratories, incident reports, and prescription queries by on-site reviewers; presence of a signal was considered an incident. Two independent physicians reviewed incidents to determine whether they were ADEs or medication errors and to assess severity and preventability. KEY RESULTS: We identified 1,010 ADEs and 514 medication errors (incidence: 17.0 and 8.7 per 1,000 patient-days, respectively) during the study period. Among ADEs, 1.6%, 4.9% and 33% were fatal, life-threatening and serious, respectively. Among ADEs, 14% were preventable. The rate per admission was 29 per 100 admissions, higher than in U.S. studies because associated with of the long length of hospital stay in Japan (mean, 17 days). CONCLUSIONS: The epidemiology and nature of ADEs and medication errors in Japan were similar to other countries, although more frequent per admission. Solutions that worked in these countries might thus improve medication safety in Japan, as could shortening hospital length of stay.

KW - adverse drug events

KW - epidemiology

KW - medication errors

KW - patient safety

UR - http://www.scopus.com/inward/record.url?scp=78751584806&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78751584806&partnerID=8YFLogxK

U2 - 10.1007/s11606-010-1518-3

DO - 10.1007/s11606-010-1518-3

M3 - Article

C2 - 20872082

AN - SCOPUS:78751584806

VL - 26

SP - 148

EP - 153

JO - Journal of General Internal Medicine

JF - Journal of General Internal Medicine

SN - 0884-8734

IS - 2

ER -